Zhan Huang - Dian Diagnostics | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 16 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Remodeling the Tumor-Immune Microenvironment by Anti-Ctla4 Blockade Enhanced Subsequent Anti-Pd-1 Efficacy in Advanced Nasopharyngeal Carcinoma

Yuxiang Ma,Huaqiang Zhou,Fan Luo,Yang Zhang,Changbin Zhu,Weiwei Li,Zhan Huang, Jingbo Zhao,Jinhui Xue,Yuanyuan Zhao,Wenfeng Fang,Yunpeng Yang,Yan Huang,Li Zhang,Hongyun Zhao

NPJ PRECISION ONCOLOGYno. 1 (2024)

引用0浏览0WOSNATURE引用

Novel Molecular Subtypes of METex14 Non-Small Cell Lung Cancer with Distinct Biological and Clinical Significance

Shengnan Chen, Tao Hu,Jikai Zhao,Qian Zhu, Jin Wang,Zhan Huang,Chan Xiang,Ruiying Zhao,Changbin Zhu,Shun Lu,Yuchen Han

npj Precision Oncologyno. 1 (2024)

引用0浏览0WOSNATURE引用

Abstract 1035: Identification of Fibroblast Growth Factor Receptors (fgfrs) Alterations (alts) at DNA and RNA-level by One-Step Next-Generation Sequencing (NGS) Panel

Min Qing,Xuejun Chen, Wenqing Su, Xiaofang Zhuo, Ting Shen, Chengjuan Xiong,Xuesong Lyu, Renee Tate,Qibiao Wu,Longen Zhou, Shibu Thomas, Wangwang Ning, Jianqing Wang, Huihui Yan, Zhiqiang Yin,Zhan Huang, Yaxin Xue, Changbin Zhu

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Homologous recombination deficiency (HRD) status to predict the efficacy and prognosis of platinum-based neoadjuvant chemotherapy in patients with triple-negative breast cancer

Xuan Jin,Minyan Chen,Hanxi Chen,Lili Chen,Yuxiang Lin,Long Wu, Ganghuai Tang,Weiwei Li,Zhan Huang,Qian Li,Changbin Zhu,Wenhui Guo,Fangmeng Fu,Chuan Wang

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): e12605-e12605

引用0浏览0引用

Multi-omic Subtyping and Molecular Determinants of Neoadjuvant Therapeutic Regimen for Locally Advanced HER2-positive and Triple-Negative Breast Cancer: Implications of Novel Therapy

Fei Ji,Xianzhe Chen,Ci-Qiu Yang,Liulu Zhang,Mei Yang,Jieqing Li,Hong-Fei Gao,Teng Zhu,Min-Yi Cheng,Yi-Tian Chen, Hao Peng,Changbin Zhu,Weiwei Li,Zhan Huang,Jin Wang,Kun Wang

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Influence of High COL19A1 Expression on the Effectiveness of Neoadjuvant Immunotherapy Plus Chemotherapy and Long-Term Survival in Patients with Esophageal Squamous Cell Carcinoma

Jianhua Liu,Jia-Tao Zhang,Changbin Zhu,Weiwei Li,Qian Li,Zhan Huang,Guibin Qiao,Yi-Long Wu

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

COL19A1 is a predictive biomarker for the responsiveness of esophageal squamous cell carcinoma patients to immune checkpoint therapy

Jian-Hua Liu,Ju-Ze Lin,Qianhui Qiu,Changbin Zhu,Weiwei Li,Qian Li,Zhan Huang,Xueer Xia,Guibin Qiao,Jiming Tang

Thoracic cancerno. 14 (2023): 1294-1305

引用1浏览0WOS引用

Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trial (vol 10, e004952, 2022)

X. Han,X. Tang,H. Zhu,D. Zhu,X. Zhang, X. Meng,Y. Hua, Z. Wang, Y. Zhang,W. Huang, L. Wang, S. Yuan,P. Zhang,H. Gong, Y. Sun, Y. Zhang, Z. Liu, X. Dong,F. Gai,Z. Huang, C. Zhu, J. Guo,Z. Wang

JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 7 (2023)

引用0浏览0引用

Concomitant Novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK Double-Fusion Variants and Confer Sensitivity to Crizotinib in Two Lung Adenocarcinoma Patients, Respectively

Tao Hong,Liu Zhe,Mu Jing,Gai Fei,Huang Zhan,Shi Liang

Diagnostic Pathology（2022）

引用3浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn